Reporting decks
Results presentations, investor updates and company reports from real companies, chosen because they are well made. Each entry links to the original deck.

Wayfair investor presentation, 2025
The deck is Wayfair's 2025 investor presentation, dated February 20, 2025, and opens with a forward-looking statements safe harbor before a contents page.

Givaudan investor presentation, 2026
The deck opens with a title slide and a short 'Who we are' section covering Givaudan's brand video, global footprint of production sites, creation centres, locations and employees, and a split of sales across its Taste & Wellbeing and Fragrance & Beauty businesses.

BMW Group investor presentation, 2026
This investor relations deck from BMW Group, dated November 2026, opens with a title slide and then sets out a vision of premium individual mobility.

HubSpot investor presentation, 2026
The deck is HubSpot's Q1 2026 investor presentation.

Owens Corning investor presentation, 2026
This Q1 2026 investor presentation from Owens Corning opens with a title slide listing the investor conferences where it was shared, followed by forward-looking statements and non-GAAP disclaimers.

Novartis investor presentation, 2026
The deck is Novartis's Q3 2026 results investor presentation, dated October 27, 2026, and presented by CEO Vas Narasimhan and CFO Mukul Mehta.

ARC Ento Tech Ltd investor presentation
The deck is a fundraising presentation for ARC Ento Tech Ltd, an Australian company seeking a $10 million Series A raise to fund six commercial plants that convert mixed municipal waste into products.

BrightView investor presentation, 2025
The deck opens with a title slide and a forward-looking statements disclaimer, then introduces BrightView as a commercial landscaping and snow services company with about 20,000 employees, $2.8B in revenue and 280 branch locations.

Key Venture presentation, 2023
The deck is a corporate profile from Key Venture, a financial services firm that advises early and growth stage startups on raising capital.

Aerbio investor presentation, 2024
The deck opens with a title slide and then a page of investment disclaimers and representations that an investor must accept, followed by the company's one-line mission of turning carbon dioxide into protein with microbes.

Capsida Biotherapeutics investor presentation, 2025
The deck opens with a title slide and a forward-looking statements disclaimer, then frames the problem with first-generation genetic medicines: poor blood-brain barrier crossing, liver and dorsal root ganglia toxicity, narrow therapeutic windows, and risky invasive routes of delivery.

MedFire Innovations Inc. investor presentation, 2023
The deck opens with a title slide labeled Exhibit A Pitch Deck, followed by a legal disclaimer and a company origin story.